Literature DB >> 2194865

Ultrasound screening for fetal urinary tract malformations: a prospective study in general population.

H Rosendahl1.   

Abstract

Routine ultrasound examination at a first level ultrasound unit was performed on 4586 fetuses in general pregnant population at 18 and 34 weeks, to detect urinary tract malformations. Suspected renal abnormality was confirmed by postnatal investigations. Infants were followed up to 2-4 years to detect any renal malformations missed in screening. Urinary tract abnormalities were observed antenatally in 27 fetuses, eight cases at 18 weeks, and 19 cases at 34 weeks. An anteroposterior diameter of renal pelvis of 1 cm or more was the criterion for fetal hydronephrosis, which was the main ultrasound finding in 18 fetuses showing 24 hydronephrotic kidneys. In five cases, slight hydronephrosis disappeared spontaneously after birth, explaining the five 'false positive' cases of the study. Four children had renal abnormalities that were missed antenatally. The incidence of true urinary tract malformations detected by screening antenatally was 0.48%, and the overall incidence after 2-4 years follow-up was 0.57%, which is much higher than reported earlier in series without routine ultrasound screening. The antenatal screening showed a sensitivity of 84.6%, a specificity of 99.9%, a positive predictive value of 81.5%, and a negative predictive value of 99.9%. The main differential diagnostic problems occurred in two fields: in differentiating (1) functional hydronephrosis from obstructive uropathy, and (2) multicystic renal dysplasia of Potter's type IV from severe hydronephrosis. The prenatal diagnosis in cases with definitive renal abnormality corresponded to the postnatal diagnosis in 19/22 (86.4%) of the cases. 68% of the infants with urinary tract anomaly survived, 60% of them undergoing postnatal surgery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2194865     DOI: 10.1016/0028-2243(90)90046-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  8 in total

Review 1.  Mild fetal renal pelvis dilatation: much ado about nothing?

Authors:  Daljit K Hothi; Angie S Wade; Ruth Gilbert; Paul J D Winyard
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 8.237

Review 2.  [Prognostic markers for congenital hydronephroses].

Authors:  S Conrad
Journal:  Urologe A       Date:  2007-02       Impact factor: 0.639

3.  Maternal obesity is associated with congenital anomalies of the kidney and urinary tract in offspring.

Authors:  Ian Macumber; Stephen Schwartz; Nicolae Leca
Journal:  Pediatr Nephrol       Date:  2016-11-17       Impact factor: 3.714

4.  Correlation of ultrasound and renal scintigraphy in children with unilateral hydronephrosis in primary workup.

Authors:  E U Nitzsche; L B Zimmerhackl; R A Hawkins; B Stöver; A Frankenschmidt; G Sigmund; Y Choi; C K Hoh; E A Moser
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 5.  A Primer on Congenital Anomalies of the Kidneys and Urinary Tracts (CAKUT).

Authors:  Vasikar Murugapoopathy; Indra R Gupta
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-18       Impact factor: 8.237

6.  Priority target conditions for algorithms for monitoring children's growth: Interdisciplinary consensus.

Authors:  Pauline Scherdel; Rachel Reynaud; Christine Pietrement; Jean-François Salaün; Marc Bellaïche; Michel Arnould; Bertrand Chevallier; Hugues Piloquet; Emmanuel Jobez; Jacques Cheymol; Emmanuelle Bichara; Barbara Heude; Martin Chalumeau
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

7.  Bedside ultrasonography screening for congenital renal anomalies in children with congenital heart diseases undergoing cardiac repair.

Authors:  Hussam K Hamadah; Omar Hijazi; Mohammad A Faraji; Mohamed S Kabbani
Journal:  J Saudi Heart Assoc       Date:  2017-09-21

8.  Prenatal natural history of isolated fetal mild bilateral pyelectasis.

Authors:  Gustavo de Paula Pereira; Victor Bunduki; Eliane Azeka Hase; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib
Journal:  Clinics (Sao Paulo)       Date:  2016-09       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.